GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr

GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr

By: IPP Bureau

Last updated : July 26, 2022 11:40 am



GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022


GlaxoSmithKline Pharmaceuticals Limited has posted net profit of Rs. 119.28 crores for the period ended June 30, 2022 as against net profit of Rs. 1219.05 crores for the period ended March 31, 2022.

The company posted net profit of Rs.121.08 crores for the period ended June 30, 2021.

GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022 as compared to Rs. 828.39 crores during the period ended March 31, 2022.

The company reported total income of Rs.750.10 crores during the period ended June 30, 2021.

GlaxoSmithKline Pharmaceuticals

First Published : July 26, 2022 12:00 am